These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Access before approval--a right to take experimental drugs? Okie S. N Engl J Med; 2006 Aug 03; 355(5):437-40. PubMed ID: 16885545 [No Abstract] [Full Text] [Related]
11. The Food and Drug Administration's use of postmarketing (Phase IV) study requirements: exception to the rule? Steenburg C. Food Drug Law J; 2006 Aug 03; 61(2):295-383. PubMed ID: 16903034 [No Abstract] [Full Text] [Related]
12. Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe. Roberts SA, Allen JD, Sigal EV. Health Aff (Millwood); 2011 Jul 03; 30(7):1375-81. PubMed ID: 21680577 [Abstract] [Full Text] [Related]
15. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration? Zelenay JL. Food Drug Law J; 2005 Jul 03; 60(2):261-338. PubMed ID: 16094773 [No Abstract] [Full Text] [Related]
16. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. Mello MM, Studdert DM, Brennan TA. N Engl J Med; 2009 Apr 09; 360(15):1557-66. PubMed ID: 19357413 [No Abstract] [Full Text] [Related]